The rare O blood type most people are curious about is the Bombay phenotype, sometimes written as Oh. It looks like type O on a standard blood test but is fundamentally different at the molecular level. While regular type O blood is relatively common, the Bombay phenotype occurs in roughly 1 in 10,000 people in India and as few as 1 in 250,000 among Europeans. People with this blood type can only receive transfusions from other Bombay phenotype donors, making it one of the rarest and most restrictive blood types known.
How It Differs From Regular Type O
To understand the Bombay phenotype, it helps to know how the standard ABO system works. Every red blood cell starts with a foundation molecule called the H antigen. Think of H as a blank canvas. In people with type A blood, an enzyme paints an “A” marker onto that canvas. Type B gets a “B” marker. Type AB gets both. Type O leaves the canvas blank, so the H antigen sits on the cell surface untouched.
People with the Bombay phenotype are missing the canvas entirely. Their bodies don’t produce the H antigen at all, so there’s nothing for the A or B enzymes to modify. On a routine blood typing test, their cells show no A, B, or H markers, which can make them appear to be ordinary type O. But the distinction matters enormously: their immune system produces antibodies against A, B, and H antigens. Regular type O blood still carries the H antigen, so transfusing it into a Bombay phenotype patient triggers a serious immune reaction.
Why the H Antigen Goes Missing
The H antigen is built by an enzyme encoded by a gene called FUT1. In the Bombay phenotype, both copies of this gene carry mutations that shut the enzyme down completely. The classic mutation is a single change in the gene’s DNA that creates a premature stop signal, cutting the enzyme short before it can function. Without working FUT1, red blood cells never get the H antigen attached to their surface.
A second gene, FUT2, controls whether H antigen appears in saliva and other body secretions. In the classic Bombay phenotype, both FUT1 and FUT2 are inactive, so the person lacks H antigen everywhere: on red blood cells, in saliva, and in other tissues. This inheritance pattern is recessive, meaning you need two nonfunctional copies of each gene. Both parents must carry at least one defective copy for a child to inherit the phenotype, which is why it’s so rare and why it clusters in populations where carriers are more common.
The Para-Bombay Variant
There’s a close relative called the para-Bombay phenotype. These individuals also have inactive FUT1 genes, so their red blood cells lack H antigen. The difference is that their FUT2 gene still works. This means they produce H antigen in saliva and secretions, and small amounts of A or B blood group substances from their plasma can passively stick to their red blood cells. Para-Bombay individuals sometimes show faint A or B reactions on sensitive lab tests, which can create confusion during blood typing. Their transfusion needs are similar to the classic Bombay phenotype, though the clinical picture can be slightly less restrictive depending on the strength of their antibodies.
How Common It Actually Is
Standard O-negative blood, often called the “universal donor” type, makes up about 7% of the population. The Bombay phenotype is in a completely different category of rarity. In India, where it was first identified in 1952, roughly 1 in 10,000 people carry it. In certain neighborhoods of Mumbai (formerly Bombay), the rate is slightly higher, around 0.01% of the population. In Europe, estimates drop to about 1 in 1,000,000, and among Caucasian populations broadly, the incidence is approximately 1 in 250,000.
A study of over 56,000 people in the southern Bengal region of India found an overall prevalence of 0.011%, confirming that even within India the phenotype remains uncommon. These numbers explain why blood banks rarely stock Bombay phenotype units and why families with this blood type are often encouraged to bank their own blood in advance of planned surgeries.
Why Transfusions Are So Complicated
The core problem is the anti-H antibody. Everyone with the Bombay phenotype naturally develops antibodies against the H antigen, in addition to the anti-A and anti-B antibodies that regular type O individuals also produce. Since virtually all donated blood, including standard type O, carries H antigen on its red cells, a Bombay phenotype patient’s immune system will attack transfused cells from any conventional blood type.
This reaction can be severe. If a Bombay phenotype patient is mistakenly given standard type O blood, their anti-H antibodies bind to the donated red cells and trigger destruction of those cells inside the bloodstream. The only safe option is blood from another Bombay phenotype donor. In emergencies where Bombay phenotype blood isn’t available, the situation becomes genuinely life-threatening, which is why correct identification matters so much.
How It Gets Detected
On a standard forward typing test (mixing the patient’s red cells with known antibodies), Bombay phenotype blood looks identical to type O because neither A nor B antigens are present. The clue shows up during reverse typing, where the patient’s serum is tested against known red blood cells. Bombay phenotype serum causes strong clumping when mixed with standard type O cells, which should not happen if the patient were simply type O. That unexpected reaction is the red flag that prompts further testing.
Confirmatory testing specifically checks for anti-H antibodies using O cells, which are rich in H antigen. When a patient’s serum agglutinates O cells strongly at room temperature and beyond, the presence of anti-H is confirmed. Additional steps using cord blood cells (which carry very little H antigen) and chemical treatments help distinguish anti-H from other look-alike antibodies. Once confirmed, the patient’s records are flagged permanently so that future transfusions use only Bombay phenotype blood.
Living With the Bombay Phenotype
Day to day, the Bombay phenotype causes no symptoms or health problems. Red blood cells function normally regardless of which surface antigens they carry. The challenge is entirely situational: any scenario requiring a blood transfusion, from surgery to trauma to childbirth, requires advance planning.
People who know they have this blood type typically register with rare blood donor programs and may store frozen units of their own blood (autologous donation) for future needs. Family members are the most likely compatible donors, since the recessive genetics mean siblings have a higher-than-average chance of sharing the phenotype. In regions of India where the Bombay phenotype is relatively more common, dedicated registries help connect donors with patients. In countries where the phenotype is exceedingly rare, international rare blood networks coordinate shipments of frozen units across borders when needed.